跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
纽莫法 - NMPA Drug Approval Details
Approvals
/
NMPA
/
23-valent Pneumococcal Polysaccharide Vaccine
Approved
生物制品
23-valent Pneumococcal Polysaccharide Vaccine
Merck, Inc.
🇨🇳 National Medical Products Administration
Approval Date
Jun 6, 2025
Approval ID
81u8kAc7D5S
Company
Merck, Inc.
Type
生物制品
Approval Details
Approval Id
81u8kAc7D5S
Approval Number
国药准字SJ20140114
Generic Name
23价肺炎球菌多糖疫苗
Generic Name En
23-valent Pneumococcal Polysaccharide Vaccine
Trade Name
纽莫法
Drug Type
生物制品
Dosage Form
注射剂
Strength
0.5ml/瓶
Reg Date
2025-06-06
Expired Date
2030-05-05
Company Name
Merck, Inc.
Production Company Name
Merck, Inc.
Company Detail Path
/organization/merck-inc
Production Company Detail Path
/organization/merck-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 6, 2025
Approval ID
81u8kAc7D5S
Type
生物制品
Back to NMPA Approvals
